Anaplastic Large Cell Lymphoma, ALK-Positive

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08870Brentuximab vedotin1 / 2Recruiting1
DB00493Cefotaxime1 / 2Active Not Recruiting1
DB09063Ceritinib1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Active Not Recruiting1
DB00997Doxorubicin1 / 2Active Not Recruiting1
DB00773Etoposide1 / 2Active Not Recruiting1
DB00480Lenalidomide1 / 2Active Not Recruiting1
DB00635Prednisone1 / 2Active Not Recruiting1
DB14546Sulfate ion1 / 2Active Not Recruiting1
DB00541Vincristine1 / 2Active Not Recruiting1
DB08870Brentuximab vedotin2Recruiting1
DB08870Brentuximab vedotin2Suspended1
DB12267Brigatinib2Recruiting1
DB00493Cefotaxime2Recruiting1
DB00493Cefotaxime2Suspended1
DB08865Crizotinib2Recruiting1
DB08865Crizotinib2Suspended1
DB00531Cyclophosphamide2Recruiting1
DB00531Cyclophosphamide2Suspended1
DB00987Cytarabine2Suspended1
DB01234Dexamethasone2Suspended1
DB00997Doxorubicin2Recruiting1
DB00997Doxorubicin2Suspended1
DB00773Etoposide2Recruiting1
DB00773Etoposide2Suspended1
DB01181Ifosfamide2Suspended1
DB12130Lorlatinib2Recruiting1
DB00563Methotrexate2Suspended1
DB06306Onalespib2Recruiting1
DB00635Prednisone2Recruiting1
DB14922Tislelizumab2Recruiting1